Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.59
Delayed Data
As of 4:00pm ET
 -0.0025 / -0.42%
Today’s Change
0.42
Today|||52-Week Range
1.30
-6.35%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close0.59
Today’s open0.58
Day’s range0.58 - 0.60
Volume71,113
Average volume (3 months)367,535
Market cap$36.3M
Dividend yield--
Data as of 4:00pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+26.19%
Earnings growth (this year)+23.66%
Earnings growth (next 5 years)--
Revenue growth (last year)-69.69%
P/E ratioNM
Price/Sales29.66
Price/Book16.56

Competitors

 Today’s
change
Today’s
% change
PPHMPPeregrine Pharmaceut...-0.17-0.74%
ACSTAcasti Pharma Inc+0.00+0.89%
GNVCGenVec Inc-0.06-2.72%
RTTRRitter Pharmaceutica...-0.31-7.75%
Data as of 3:59pm ET, 07/30/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1M
Annual profit (last year)-$15.2M
Net profit margin-1,441.56%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ramin Najafi
CFO, CAO, Secretary &
Treasurer
Thomas J. Paulson
Corporate headquarters
Emeryville, California

Forecasts